Pain Therapeutics reported $-9541000 in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3042M 769M
Acelrx Pharmaceuticals ACRX:US $ -8.15M 0.96M
Acura Pharmaceuticals ACUR:US -282000 154K
Amgen AMGN:US $ 3228M 40M
Biogen BIIB:US $ 991.8M 155.8M
Eisai 4523:JP Y 15346M 49516M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Geron GERN:US $ -25.62M 3.22M
Johnson & Johnson JNJ:US $ 8192M 2043M
Novartis NOVN:VX SF 4837M 65M
Novavax NVAX:US $ -302.88M 40.54M
Pain Therapeutics PTIE:US $ -9.54M 4.41M
Pfizer PFE:US $ 10235M 2245M